NO20082482L - Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer - Google Patents

Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer

Info

Publication number
NO20082482L
NO20082482L NO20082482A NO20082482A NO20082482L NO 20082482 L NO20082482 L NO 20082482L NO 20082482 A NO20082482 A NO 20082482A NO 20082482 A NO20082482 A NO 20082482A NO 20082482 L NO20082482 L NO 20082482L
Authority
NO
Norway
Prior art keywords
kinase inhibitors
carbonylamino
pyrazoles
pyrrole
well
Prior art date
Application number
NO20082482A
Other languages
English (en)
Norwegian (no)
Inventor
Jayashree Girish Tikhe
Indrawan James Mcalpine
Haitao Li
Anle Yang
Junhu Zhang
Liming Dong
Chuangxing Guo
Yufeng Hong
Mary Catherine Johnson
Susan Elizabeth Kephart
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20082482L publication Critical patent/NO20082482L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20082482A 2005-12-21 2008-06-02 Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer NO20082482L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75334905P 2005-12-21 2005-12-21
US86493206P 2006-11-08 2006-11-08
PCT/IB2006/003646 WO2007072153A2 (fr) 2005-12-21 2006-12-12 Carbonylaminopyrrolopyrazoles, inhibiteurs puissants de kinase

Publications (1)

Publication Number Publication Date
NO20082482L true NO20082482L (no) 2008-07-02

Family

ID=38189022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082482A NO20082482L (no) 2005-12-21 2008-06-02 Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer

Country Status (27)

Country Link
US (1) US7884117B2 (fr)
EP (1) EP1979356B1 (fr)
JP (1) JP4635089B2 (fr)
KR (1) KR101029167B1 (fr)
AP (1) AP2369A (fr)
AU (1) AU2006327866B2 (fr)
BR (1) BRPI0620354A2 (fr)
CA (1) CA2634381C (fr)
CR (1) CR10094A (fr)
CU (1) CU23751B7 (fr)
DK (1) DK1979356T3 (fr)
EA (1) EA015513B1 (fr)
EC (1) ECSP088558A (fr)
ES (1) ES2435405T3 (fr)
GE (1) GEP20104974B (fr)
HK (1) HK1128290A1 (fr)
HR (1) HRP20130976T1 (fr)
IL (1) IL191776A (fr)
MA (1) MA30076B1 (fr)
ME (1) ME00006B (fr)
MY (1) MY151455A (fr)
NO (1) NO20082482L (fr)
NZ (1) NZ568692A (fr)
PL (1) PL1979356T3 (fr)
PT (1) PT1979356E (fr)
RS (2) RS53029B (fr)
WO (1) WO2007072153A2 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL385265A1 (pl) * 2008-05-23 2009-12-07 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania solifenacyny i/lub jej soli o wysokiej czystości farmaceutycznej
CA2744987C (fr) 2008-12-02 2018-01-16 Chiralgen, Ltd. Procede pour la synthese d'acides nucleiques modifies par des atomes de phosphore
BR112012000828A8 (pt) 2009-07-06 2017-10-10 Ontorii Inc Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
EP2519517B1 (fr) 2009-12-29 2015-03-25 Dana-Farber Cancer Institute, Inc. Inhibiteurs de kinase raf de type ii
US10428019B2 (en) * 2010-09-24 2019-10-01 Wave Life Sciences Ltd. Chiral auxiliaries
RU2013126036A (ru) 2010-11-17 2014-12-27 Ф. Хоффманн-Ля Рош Аг Способ лечения опухолей
US8771682B2 (en) 2011-04-26 2014-07-08 Technische Universtität Dresden Methods and compositions for reducing interleukin-4 or interleukin-13 signaling
RU2014105311A (ru) 2011-07-19 2015-08-27 Уэйв Лайф Сайенсес Пте. Лтд. Способы синтеза функционализованных нуклеиновых кислот
EP2822935B1 (fr) 2011-11-17 2019-05-15 Dana-Farber Cancer Institute, Inc. Inhibiteurs de la kinase c-jun-terminale (jnk)
WO2013135745A1 (fr) 2012-03-16 2013-09-19 F. Hoffmann-La Roche Ag Procédés de traitement d'un mélanome avec des inhibiteurs de pak1
MX356830B (es) 2012-07-13 2018-06-15 Shin Nippon Biomedical Laboratories Ltd Adyuvante de acido nucleico quiral.
SG10201912895PA (en) 2012-07-13 2020-02-27 Wave Life Sciences Ltd Chiral control
JP6268157B2 (ja) 2012-07-13 2018-01-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ 不斉補助基
EP2909194A1 (fr) 2012-10-18 2015-08-26 Dana-Farber Cancer Institute, Inc. Inhibiteurs de cycline-dépendante kinase 7 (cdk7)
WO2014063061A1 (fr) 2012-10-19 2014-04-24 Dana-Farber Cancer Institute, Inc. Petites molécules marquées de façon hydrophobe en tant qu'inducteurs de la dégradation de protéine
US10000483B2 (en) 2012-10-19 2018-06-19 Dana-Farber Cancer Institute, Inc. Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
US20160264551A1 (en) 2013-10-18 2016-09-15 Syros Pharmaceuticals, Inc. Heteroaromatic compounds useful for the treatment of prolferative diseases
EP3057956B1 (fr) 2013-10-18 2021-05-05 Dana-Farber Cancer Institute, Inc. Inhibiteurs polycycliques de la kinase cycline-dépendante 7 (cdk7)
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
JPWO2015108046A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
WO2015108048A1 (fr) 2014-01-15 2015-07-23 株式会社新日本科学 Adjuvant d'acide nucléique chiral ayant un effet antitumoral et agent antitumoral
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인
WO2015164614A1 (fr) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Inhibiteurs de janus kinase et leurs utilisations
WO2015164604A1 (fr) 2014-04-23 2015-10-29 Dana-Farber Cancer Institute, Inc. Inhibiteurs de janus kinase marqués de manière hydrophobe et utilisations associées
WO2016068287A1 (fr) 2014-10-31 2016-05-06 宇部興産株式会社 Composé de dihydropyrrolopyrazole substitué
WO2016105528A2 (fr) * 2014-12-23 2016-06-30 Dana-Farber Cancer Institute, Inc. Inhibiteurs de la kinase cycline-dépendante 7 (cdk7)
US10550121B2 (en) 2015-03-27 2020-02-04 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
WO2016201370A1 (fr) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Thérapie d'association utilisant des inhibiteurs de transcription et des inhibiteurs de kinases
RU2765718C1 (ru) * 2015-06-15 2022-02-02 Убе Индастриз, Лтд. Замещенное производное дигидропирролопиразола
EP4019515A1 (fr) 2015-09-09 2022-06-29 Dana-Farber Cancer Institute, Inc. Inhibiteurs de kinases cycline-dépendantes
WO2017144546A1 (fr) 2016-02-23 2017-08-31 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pharmaceutiques pour le traitement d'un carcinome de rhinopharyngite
EP3885347B1 (fr) 2018-11-14 2023-11-22 UBE Corporation Dérivé de dihydropyrrolopyrazole
CN113557017A (zh) * 2018-12-28 2021-10-26 达纳-法伯癌症研究所股份有限公司 细胞周期蛋白依赖性激酶7的抑制剂及其用途
EP3956446A1 (fr) 2019-04-17 2022-02-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Procédés et compositions de traitement de troubles dépendants de il-1beta mediés par inflamasome nlrp3
WO2021198511A1 (fr) 2020-04-03 2021-10-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et compositions pour le traitement d'une infection par sars-cov-2
WO2022008597A1 (fr) 2020-07-08 2022-01-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Méthodes et composition pharmaceutique pour le traitement de maladies infectieuses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006381B1 (ru) * 2000-08-10 2005-12-29 Фармация Италия С.П.А. Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
JP2005537290A (ja) 2002-07-25 2005-12-08 ファルマシア・イタリア・エス・ピー・エー キナーゼ阻害剤として活性なビシクロピラゾール類、その製造方法、およびそれを含有する薬学的組成物
UA81790C2 (uk) 2002-12-19 2008-02-11 Фармация Италия С.П.А. Заміщені піролопіразольні похідні як інгібітори кінази
GB0229526D0 (en) 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
CA2539549A1 (fr) * 2003-09-23 2005-04-07 Vertex Pharmaceuticals Incorporated Derives de pyrazolopyrrole utilises en tant qu'inhibiteurs de proteines kinases
CA2593428C (fr) * 2005-01-10 2012-04-17 Pfizer Inc. Pyrrolopyrazoles, puissants inhibiteurs de kinases

Also Published As

Publication number Publication date
JP4635089B2 (ja) 2011-02-16
CA2634381A1 (fr) 2007-06-28
KR20080080567A (ko) 2008-09-04
AP2369A (en) 2012-02-29
AU2006327866A1 (en) 2007-06-28
KR101029167B1 (ko) 2011-04-12
MY151455A (en) 2014-05-30
IL191776A (en) 2013-03-24
AU2006327866B2 (en) 2012-06-14
PT1979356E (pt) 2013-11-21
EP1979356B1 (fr) 2013-09-18
MEP0808A (xx) 2010-02-10
MA30076B1 (fr) 2008-12-01
BRPI0620354A2 (pt) 2011-11-08
CR10094A (es) 2008-08-01
EP1979356A2 (fr) 2008-10-15
ME00006B (fr) 2010-02-10
US20090318440A1 (en) 2009-12-24
WO2007072153A3 (fr) 2007-10-25
WO2007072153A2 (fr) 2007-06-28
RS53029B (en) 2014-04-30
ES2435405T3 (es) 2013-12-19
JP2009520805A (ja) 2009-05-28
WO2007072153A8 (fr) 2008-08-14
PL1979356T3 (pl) 2014-01-31
GEP20104974B (en) 2010-04-26
EA200801291A1 (ru) 2008-12-30
ECSP088558A (es) 2008-07-30
DK1979356T3 (da) 2013-11-18
NZ568692A (en) 2011-07-29
IL191776A0 (en) 2008-12-29
US7884117B2 (en) 2011-02-08
HK1128290A1 (en) 2009-10-23
EA015513B1 (ru) 2011-08-30
AP2008004506A0 (en) 2008-06-30
CU23751B7 (es) 2012-01-31
CU20080115A7 (es) 2010-08-30
HRP20130976T1 (hr) 2013-11-22
CA2634381C (fr) 2011-03-08
RS20080281A (en) 2009-09-08

Similar Documents

Publication Publication Date Title
NO20082482L (no) Karbonylamino pyrrolpyrazoler, samt anvendelse som kinase inhibitorer
CY1111752T1 (el) Πυρρολοπυραζολες, δυναμικοι αναστολεις κινασης
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
WO2007079164A3 (fr) Inhibiteurs de protéines kinases
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
NO20070555L (no) Kinazolinonderivater som parp-inhibitorer
NO20053470L (no) Triazolopyridaziner som proteinkinase-inhibitorer
NO20071619L (no) Fremgangsmate for fremstilling av indazol forbindelse
ATE420879T1 (de) Indolizine als kinaseproteinhemmer
NO20051100L (no) Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer
ATE479687T1 (de) Kinaseinhibitoren
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
WO2006050109A3 (fr) Nouveaux inhibiteurs de kinase
NO20054080L (no) Aminoheteroarylforbindelser som roteinkinaseinhibitorer
ATE433447T1 (de) Pyrimiidinverbindungen
NO20072058L (no) Inhibitorer av interaksjonen mellom MDM2 og P53
MX2008001538A (es) Aril piridinas y metodos para su uso.
ATE532781T1 (de) 5-(acylamino)indazol-derivate als kinase- inhibitoren
NO20050828L (no) lndol-3-svovelderivater
EA201000494A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
UA85505C2 (en) Kinase inhibitors
NO20082256L (no) Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
EA201270630A1 (ru) Гетероциклические сетр ингибиторы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application